LLY

781.2

+2.09%↑

JNJ

150.35

+0.47%↑

NVO

69.35

-6.11%↓

ABBV

184.61

-0.23%↓

UNH

298.34

-1.16%↓

LLY

781.2

+2.09%↑

JNJ

150.35

+0.47%↑

NVO

69.35

-6.11%↓

ABBV

184.61

-0.23%↓

UNH

298.34

-1.16%↓

LLY

781.2

+2.09%↑

JNJ

150.35

+0.47%↑

NVO

69.35

-6.11%↓

ABBV

184.61

-0.23%↓

UNH

298.34

-1.16%↓

LLY

781.2

+2.09%↑

JNJ

150.35

+0.47%↑

NVO

69.35

-6.11%↓

ABBV

184.61

-0.23%↓

UNH

298.34

-1.16%↓

LLY

781.2

+2.09%↑

JNJ

150.35

+0.47%↑

NVO

69.35

-6.11%↓

ABBV

184.61

-0.23%↓

UNH

298.34

-1.16%↓

Search

Agilent Technologies Inc

Aperta

SettoreSettore sanitario

115.84 0.2

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

113.65

Massimo

116.01

Metriche Chiave

By Trading Economics

Entrata

-103M

215M

Vendite

-13M

1.7B

P/E

Media del settore

28.837

50.857

EPS

1.31

Rendimento da dividendi

0.85

Margine di Profitto

12.89

Dipendenti

18,000

EBITDA

-94M

373M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+18.09% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.85%

2.35%

Utili prossimi

20 ago 2025

Prossima data del Dividendo

23 lug 2025

Prossima data del' Ex Dividendo

1 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-5.6B

33B

Apertura precedente

115.64

Chiusura precedente

115.84

Notizie sul Sentiment di mercato

By Acuity

85%

15%

353 / 381 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

Agilent Technologies Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 ago 2024, 09:29 UTC

Utili

UBS Net Profit Beats Expectations on Credit Suisse Savings -- 3rd Update

14 gen 2025, 13:05 UTC

Acquisizioni, Fusioni, Takeovers

Topicus.com in Agreement to Acquire Cipal Schaubroeck in Belgium >

Confronto tra pari

Modifica del prezzo

Agilent Technologies Inc Previsione

Obiettivo di Prezzo

By TipRanks

18.09% in crescita

Previsioni per 12 mesi

Media 136.46 USD  18.09%

Alto 165 USD

Basso 115 USD

Basato su 13 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Agilent Technologies Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

13 ratings

7

Acquista

6

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

107.45 / 109.25Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

353 / 381 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.